Research Tools

Liquid biopsies (LBx), which, to-date, have been used largely for genomic profiling and therapy selection, are finding new applications throughout the patient journey and within pharma research. To help predict the future state of the market, we have developed an evaluation framework to identify and assess areas of growth within the liquid biopsy market.

This report provides a summary of oncology genomics testing practices, oncologist perspectives and experiences with test providers, and expected future utilization behaviors in Europe. A subscription to this report includes 2 waves of data, collected biannually.

This report provides a summary of oncology genomics testing practices, oncologist perspectives and experiences with test providers, and expected future utilization behaviors. A subscription to this report includes 4 waves of data, collected on a quarterly basis (4 reports total, delivered once a quarter).

Blood-based biomarkers are emerging in neurodegenerative disease testing, enabling earlier, less invasive detection and monitoring. This analysis maps activity across clinical trials, publications, pharma pipelines, and routine clinical use to benchmark key biomarkers, disease focus areas, and leading industry players driving this shift.